Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women

Abstract

Objective:

The study aimed to characterize the lipid and apolipoprotein profile and the prevalence of cardiovascular risk factors in a population of urban adult women of Morocco.

Design:

A total of 213 women 25–55 y old were sampled from an agricultural province of Morocco: El Jadida. The following parameters of lipid and apolipoprotein profile were measured: plasma triglycerides (TG), plasma cholesterol (TC), triglyceride-rich lipoprotein triglycerides (TRL-TG), TRL-cholesterol (TRL-C), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and apolipoproteins A1, B, B48, CIII and E. Waist circumference (WC), body mass index (BMI) and blood pressure (BP) were also determined.

Results:

The women studied showed the following pattern: elevated TC, LDL-C levels and TC/HDL-C in 10, 19.4 and in 43.8%, respectively; low HDL-C levels in 45.3% (<0.9 mmol/l) or in 95% (when the cutoff <1.3 mmol/l is used), elevated TG levels in 11.8%. Elevated TRL-C (>0.6 mmol/l) and TRL-TG (>0.8 mmol/l) were observed in 13.4%. Obesity and hypertension were highly prevalent in 23.9 and 16.5%, respectively. Plasma triglyceride concentrations were closely correlated with plasma concentrations of TRL-TG (R=0.86, P=0.0001), apoB (R=0.50, P=0.0001) and apoCIII (R=0.52, P=0.0001) and moderately correlated with HDL-C levels (R=−0.3, P=0.0001) and BMI (R=0.4, P=0.0001). The association between BMI and systolic blood pressure was statistically significant (R=0.3, P=0.0001). Obesity, BP, TRL-C, TRL-TG, TG, apoB and apoCIII increased with age.

Conclusion:

There is a high prevalence of some risk factors for cardiovascular disease including altered lipid and lipoprotein profiles in the Moroccan urban women studied, some of these risk factors are associated with age.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Allain CC, Poon LS, Chan CS, Richmond W & Fu PC (1974): Enzymatic determination of total serum cholesterol. Clin. Chem. 20, 470–475.

    CAS  Google Scholar 

  • Alsayed N, Rebourcet R & Chapman J (1990): Concentrations of apolipoprotein CII, CIII, and E in total serum and in the apolipoprotein B-containing lipoproteins, determined by a new ELISA. Clin. Chem. 36, 2047.

    CAS  PubMed  Google Scholar 

  • Agence Nationale d'Accréditation et d'Evaluation en Sante (ANAES) (2001): [Methods of measurement and biological diagnosis of the dyslipidemias in primary prevention. Text of the recommendations January 2000. L'Agence Nationale d'Accréditation et d'Evaluation en Sante (ANAES)]. J. Mal. Vasc. 26, 55–59.

  • Assmann G, Schulte H & Cullen P (1997): New and classical risk factors—the Munster heart study (PROCAM). Eur. J. Med. Res. 2, 237–242.

    CAS  PubMed  Google Scholar 

  • Bao W, Srinivasan SR, Wattigney WA & Berenson GS (1995): The relation of parental cardiovascular disease to risk factors in children and young adults. The Bogalusa Heart Study. Circulation 91, 365–371.

    Article  CAS  Google Scholar 

  • Barrett-Connor E & Khaw K (1984): Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 69, 1065–1069.

    Article  CAS  Google Scholar 

  • Belahsen R, Mziwira M & Fertat F (2004): Anthropometry of women of childbearing age in Morocco: body composition and prevalence of overweight and obesity. Public Health Nutr. 7, 523–530.

    Article  Google Scholar 

  • Breslow JL (1988): Apolipoprotein genetic variation and human disease. Physiol. Rev. 68, 85–131.

    Article  CAS  Google Scholar 

  • Brousseau T, Clavey V, Bard JM & Fruchart JC (1993): Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles. Clin. Chem. 39, 960–964.

    CAS  PubMed  Google Scholar 

  • Bush TL (1996): Evidence for primary and secondary prevention of coronary artery disease in women taking estrogen replacement therapy. Eur. Heart J. 17 (Suppl D), S9–S14.

    Article  Google Scholar 

  • Cambou JP, Arveiler D, Amouyel P, Ruidavets JB, Haas B, Montaye M, Bingham A & Richard JL (1996): Coronary disease in France: data from the MONICA registers (1985–1991). Rev. Epidemiol. 44, S46–S52.

    Google Scholar 

  • Chabir R, Khaldoun J, Bour A, Kadiri H, Belahsen R, Aguenaou H & et Mokhtar N (1998): Profiles socio-démographique, clinique, biologique et nutritionnel d'une population de femmes marocaines, obèses, en âge de procréer et issue de la même région. Diabetes & Metabolism 24 (Suppl), p29, p104.

    Google Scholar 

  • Chaturvedi N, Jarrett J, Morrish N, Keen H & Fuller JH (1996): Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 y follow up of a London cohort of a multinational study. BMJ 313, 848–852.

    Article  CAS  Google Scholar 

  • Connelly PW, MacLean DR, Horlick L, O'Connor B, Petrasovits A & Little JA (1992): Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 146, 1977–1987.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Davignon J, Gregg RE & Sing CF (1988): Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8, 1–21.

    CAS  Google Scholar 

  • Dubois G (1991): La cholestérolémie en France. Concours Méd. 113, 1162–1163.

    Google Scholar 

  • ERICA Research Group (1988): The CHD risk-map of Europe. The 1st report of the WHO-ERICA project. By the ERICA Research Group. Eur. Heart J. 9 (Suppl I), S1–S36.

  • Fievet-Desreumaux C, Dedonder-Decoopman E, Dewailly P, Sezille G & Jaillard J (1980): Immunochemical determination of human apolipoprotein A-I by laser nephelometry. Clin. Chim. Acta 107, 145–148.

    Article  CAS  Google Scholar 

  • Fievet-Desreumaux C, Dedonder-Decoopman E, Fruchart JC, Dewailly P & Sezille G (1979): Immunochemical determination of human apolipoprotein B by laser nephelometry. Clin. Chim. Acta 95, 405–408.

    Article  CAS  Google Scholar 

  • Fossati P & Prencipe L (1982): Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28, 2077–2080.

    CAS  Google Scholar 

  • Francis MC & Frohlich JJ (2001): Coronary artery disease in patients at low risk: apolipoprotein AI as an independent risk factor. Atherosclerosis 155, 165–170.

    Article  CAS  Google Scholar 

  • Fredenrich A, Giroux LM, Tremblay M, Krimbou L, Davignon J & Cohn JS (1997): Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J. Lipid. Res. 38, 1421–1432.

    CAS  PubMed  Google Scholar 

  • Friedewald WT, Levy RI & Fredrickson DS (1972): Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.

    CAS  Google Scholar 

  • Fuller JH, Shipley MJ, Rose G, Jarrett RJ & Keen H (1980): Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1, 1373–1376.

    Article  CAS  Google Scholar 

  • Ghannem H & Hadj Fredj A (1997): Prevalence of cardiovascular risk factors in the urban population of Soussa in Tunisia. J. Public Health Med. 19, 392–396.

    Article  CAS  Google Scholar 

  • Gotto Jr AM, Assmann G, Carmena R, Davignon J, Fernández-Cruz A & Fruchart JC (2000): The ILIB Lipid Handbook for Clinical Practice: Blood Lipids and Coronary Heart Disease 2nd Edition, p52–53, p201, New York: International Lipid Information Bureau.

    Google Scholar 

  • Harris N, Galpchian V & Rifai N (1996): Three routine methods for measuring high-density lipoprotein cholesterol compared with the reference method. Clin. Chem. 42, 738–743.

    CAS  PubMed  Google Scholar 

  • Hubert HB, Feinleib M, McNamara PM & Castelli WP (1983): Obesity as an independent risk factor for cardiovascular disease: a 26-y follow-up of participants in the Framingham Heart Study. Circulation 67, 968–977.

    Article  CAS  Google Scholar 

  • Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H & Bakillah A (1996): Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim. Biophys. Acta 1300, 151–170.

    Article  CAS  Google Scholar 

  • Jeffery RW, Wing RR & French SA (1992): Weight cycling and cardiovascular risk factors in obese men and women. Am. J. Clin. Nutr. 55, 641–644.

    Article  CAS  Google Scholar 

  • Kannel WB (1975): Role of blood pressure in cardiovascular disease: the Framingham Study. Angiology 26, 1–14.

    Article  CAS  Google Scholar 

  • Labeur C, Shepherd J & Rosseneu M (1990): Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin. Chem. 36, 591–597.

    CAS  PubMed  Google Scholar 

  • Lapierre R & Couture R (1995): Study of cadiovascular health in Lac-St-Jean-Chibougamau: the prevalence of risk factors. Union Méd. Can. 124, 22–26.

    CAS  PubMed  Google Scholar 

  • Lenfant C & Savage PJ (1995): The early natural history of atherosclerosis and hypertension in the young: National Institutes of Heath perspectives. Am. J. Med. Sci. 310, S3–S7.

    Article  Google Scholar 

  • Lorec AM, Juhel C, Pafumi Y, Portugal H, Pauli AM, Lairon D & Defoort C (2000): Determination of apolipoprotein B-48 in plasma by a competitive ELISA. Clin. Chem. 46, 1638–1642.

    CAS  PubMed  Google Scholar 

  • Luke A, Cooper RS, Prewitt TE, Adeyemo AA & Forrester TE (2001): Nutritional consequences of the African diaspora. Annu. Rev. Nutr. 21, 47–71.

    Article  CAS  Google Scholar 

  • Mahley RW & Huang Y (1999): Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10, 207–217.

    Article  CAS  Google Scholar 

  • Mediene-Benchekor S, Brousseau T, Richard F, Benhamamouch S & Amouyel P (2001): Blood lipid concentrations and risk of myocardial infarction. Lancet 358, 1064–1065.

    Article  CAS  Google Scholar 

  • Mekki N, Christofilis MA, Charbonnier M, Atlan-Gepner C, Defoort C, Juhel C, Borel P, Portugal H, Pauli AM, Vialettes B & Lairon D (1999): Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J. Clin. Endocrinol. Metab. 84, 184–191.

    CAS  PubMed  Google Scholar 

  • Mokhtar N, Belahsen R & Aguenaou H (1997): Heart disease prevalence in women of two Moroccan communities. Can. J. Cardiol. 13, S58.

    Google Scholar 

  • National Center for Health Statistics (1991): Vital Statistics of the United State. Mortality Part B. Hhyattsville: NCHS.

  • NCEP (2001): Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.

  • O'Brien T, Nguyen TT, Hallaway BJ, Hodge D, Bailey K, Holmes D & Kottke BA (1995): The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease. Arterioscler. Tromb. Vasc. Biol. 15, 228–231.

    Article  CAS  Google Scholar 

  • Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH & Schaefer EJ (1995): Gene–diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 118, S11–S12.

    Article  CAS  Google Scholar 

  • Pascot A, Lemieux I, Bergeron J, Tremblay A, Nadeau A, Prud'homme D, Couillard C, Lamarche B & Despres JP (2002): HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis 160, 399–406.

    Article  CAS  Google Scholar 

  • PDAY (1990): A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA 264, 3018–3024.

  • Sans S, Kesteloot H & Kromhout D (1997): The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur. Heart J. 18, 1231–1248.

    Article  Google Scholar 

  • Santamarina-Fojo S (1992): Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein CII. Curr. Opin. Lipidol. 3, 186–195.

    Article  CAS  Google Scholar 

  • Santé Québec (1990): Faits saillants de l'enquête Quebécoise sur la santé cardiovasculaire pp 23–36. Montréal: Interressource.

  • Schaefer EJ, Lamon-Flava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP & Wilson PW (1994): Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res. 35, 779–792.

    CAS  PubMed  Google Scholar 

  • Schonfeld G, George PK, Miller J, Reilly P & Witztum J (1979): Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism 28, 1001–1010.

    Article  CAS  Google Scholar 

  • Shaw LW (1981): Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after myocardial infarction. The National Exercise and Heart Disease Project. Am. J. Cardiol. 48, 39–46.

    Article  CAS  Google Scholar 

  • Slack J (1969): Risk of ischemic heart disease in familial hyperlipoproteinaemic states. Lancet 2, 380–382.

    Google Scholar 

  • Stamler J, Wentworth D & Neaton JD (1986): Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256, 2823–2828.

    Article  CAS  Google Scholar 

  • Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N & Miyauchi K (1995): Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin. Chem. 41, 717–723.

    CAS  PubMed  Google Scholar 

  • Von Hafe P, Lopes C, Maciel MJ & Barros H (1998): The clustering of cardiovascular risk factors in the urban population of Porto. Acta Med. Port. 11, 1059–1064.

    CAS  PubMed  Google Scholar 

  • Walldius G, Jungner I, Holme I, Aastyeit AH, Kolar W & Steiner E (2001): High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358, 2026–2033.

    Article  CAS  Google Scholar 

  • Westerveld HT, van Lennep JE, van Lennep HW, Liem AH, de Boo JA, van der Schouw YT & Erkelens DW (1998): Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their fist coronary angiography. Arterioscler. Thromb. Vasc. Biol. 18, 1101–1107.

    Article  CAS  Google Scholar 

  • WHO (1995): Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization Tech Rep Ser, Vol 854, pp 1–452.

  • WHO (1997): The World Health Report 1997—conquering suffering, enriching humanity. World Health Forum 18, 248–260.

  • Woo J, Ho SC, Chan SG, Sham A, Yuen YK & Masarei JL (1993): Lipid profile in the Chinese old-old: comparison with younger age groups and relationship with some cardiovascular risk factors and presence of diseases. Cardiology 83, 407–414.

    Article  CAS  Google Scholar 

  • Wood D, De Backer G, Faergeman O, Graham I, Mancia G & Pyorala K (1998): Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Blood Press. 7, 262–269.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study has been carried out with the financial support (Joint grant) of INSERM (Institut National de la Santé et de la Recherche Medicale, France) and CNCPRST (Centre National de Coopération et de Recherche Scientifique, Morocco), and the Provence-Alpes-Côte d'Azur Regional council. El ayachi M was INSERM postdoctoral Fellow at INSERM Unit 476, Marseille, France.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Belahsen.

Additional information

Guarantors: R Belahsen and M El ayachi.

Contributors: DL and RB: Principal investigators (project responsibles). MEla, MM and RB: Realization of the survey. MEla, MM, SV, CD and HP: Laboratory analysis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El ayachi, M., Mziwira, M., Vincent, S. et al. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women. Eur J Clin Nutr 59, 1379–1386 (2005). https://doi.org/10.1038/sj.ejcn.1602251

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602251

Keywords

This article is cited by

Search

Quick links